Do Clinical Markers of Hyperandrogenism Relate to the Response of Acne to Conventional Therapy?

    R. A. Sheehan-Dare, A. M. Layton, B.R. Hughes, W. J. Cunliffe
    TLDR Clinical features of hyperandrogenism do not predict the success of conventional acne treatment in women.
    In a study from 1990, 60 women with acne that was resistant to conventional antibiotic therapy were compared to 60 women whose acne had responded to such therapy to assess the relationship between clinical markers of hyperandrogenism and treatment response. The study found no significant difference between the two groups in terms of hirsutism scores, age at menarche, the incidence of various skin conditions, or menstrual irregularity. The results indicated that clinical features of hyperandrogenism are not associated with the effectiveness of conventional antibiotic therapy for acne, suggesting that these markers cannot be used to predict which female patients will benefit from this treatment approach.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 7 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Spironolactine Update: 2 months (34, Female)

      in Female  23 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 1 year ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

    Related Research

    8 / 8 results